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Growing evidence has emerged that subgroups of cancer
patients have a spontaneous T cell-centered immune
response reflected by infiltration of antigen-specific CD8+
T cells into the tumor microenvironment. However,
another major subgroup of patients completely lacks
T cell infiltration. Importantly, the presence of tumor-
infiltrating CD8+ T cells has been correlated with clinical
response to anti-PD-1 mAb and other immunotherapies.
Recent work from our laboratory has revealed that acti-
vation of the Wnt/b-catenin pathway within tumor cells
can mediate exclusion of T cells from the tumor micro-
environment. Using an autochthonous inducible mouse
model for melanoma (BrafV600E/PTEN-/-; BP) with or
without stabilized b-catenin (BrafV600E/PTEN-/-/CAT-
STA; BPC) we showed that T cell exclusion from the
tumor microenvironment was due to failed recruitment
of Batf3-lineage dendritic cells, resulting in a defective
early T cell priming and absence of systemic immunity.
However, whether tumor-intrinsic b-catenin signaling
might mediate tumor resistance after an anti-tumor
T cell response was established is not known. To test this
notion, we used a spontaneously rejected cell line
(MC57.SIY) to induce immunologic memory. These
tumors were implanted into naïve BP and BPC mice that
had been crossed to a Rosa26-LSL-SIY inducible antigen
mouse and following complete regression of the primary
(MC57.SIY) tumor, the genetically-induced melanomas
were initiated. Although the primary SIY-specific CD8+
T cell response and the induced memory response were
comparable between both tumor models, tumor protec-
tion was observed against BP-SIY tumors but not BPC-
SIY tumors. Increased tumor control in BP-SIY mice was
accompanied by strong T cell infiltration and a boosted
memory response. These results indicate that tumor-
intrinsic b-catenin signaling can mediate exclusion of
effector T cell migration. To test this notion directly, we
adoptively transferred in vitro-activated SIY-reactive
T cell receptor transgenic T cells (2C T cells) into BP-
SIY and BPC-SIY tumor-bearing hosts. In fact, primed
2C cells were only found in BP-SIY tumors but not BPC-
SIY tumors. These results were confirmed using in vivo
2-photon microscopy of the tumor microenvironment.
Taken together, these data provide strong evidence that
up-regulation of tumor-intrinsic b-catenin is a strong
mechanism of immune evasion even in the presence of
immunologic memory. As such, mechanisms of immune
surveillance and editing of tumors expand beyond anti-
gen-loss but additionally via specific up-regulation of
oncogene pathways. Moreover, tumor-intrinsic b-catenin
activation likely can mediate resistance not only to
checkpoint blockade but also T cell adoptive transfer.
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